Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program
Circulation Solomon et al.
110: 2180
Previous Version of This Article
The version of the article “Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program” by Solomon et al that posted online on October 4, 2004, and appeared in print in the October 12, 2004, issue of the journal (Circulation. 2004;110:2180--2183) was inadvertently published with several typographical errors. The corrected version now has replaced the previous version online. The previously published version is available in PDF format below. An erratum appears in the January 25, 2005, issue of the journal (Circulation. 2005;111:378). We regret this error.
Files in this Data Supplement: